These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 402021)

  • 1. [Myasthenia gravis. New results on etiology, diagnosis and therapy].
    Jerusalem F
    Schweiz Med Wochenschr; 1977 Jan; 107(3):65-8. PubMed ID: 402021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravis.
    Heilbronn E; Lefvert AK; Stålberg E
    Muscle Nerve; 1978; 1(5):427-31. PubMed ID: 263985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
    J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopharmacological treatment in myasthenia gravis.
    Nyberg-Hansen R; Gjerstad L
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):201-10. PubMed ID: 3289206
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of acetylcholine receptor antibodies in myasthenia gravis].
    Zeitlhofer J; Maida EM; Mamoli B; Mayr N
    Wien Med Wochenschr; 1986 Jul; 136(13):329-32. PubMed ID: 3765651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amount of circulating acetylcholine receptor antibodies in the course of myasthenia, following thymectomy and in immunosuppressive therapy].
    Patzold U; Kalies I; Haas J; Ginda EM
    Nervenarzt; 1984 Aug; 55(8):426-31. PubMed ID: 6483064
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 1.
    Simpson JA
    Muscle Nerve; 1978; 1(1):45-56. PubMed ID: 377070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental autoimmune myasthenia gravis: can pretreatment with 125I-labeled receptor prevent functional damage at the neuromuscular junction?
    Sterz RK; Biro G; Rajki K; Filipp G; Peper K
    J Immunol; 1985 Feb; 134(2):841-6. PubMed ID: 2578165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis--current concepts.
    Herrmann C; Lindstrom JM; Keesey JC; Mulder DG
    West J Med; 1985 Jun; 142(6):797-809. PubMed ID: 3895751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia and the neuromuscular junction.
    Gilhus NE
    Curr Opin Neurol; 2012 Oct; 25(5):523-9. PubMed ID: 22892950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ocular myasthenia: a diagnostic and management challenge--a review].
    Langmann A; Lindner S; Koch M; Diez J
    Klin Monbl Augenheilkd; 2004 Feb; 221(2):77-86. PubMed ID: 14986204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-fiber electromyography during menstrual exacerbation and ovulatory suppression in MuSK antibody-positive myasthenia gravis.
    Stickler DE; Stickler LL
    Muscle Nerve; 2007 Jun; 35(6):808-11. PubMed ID: 17221882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical statistics of myasthenia gravis in Japan.
    Uono MI
    Int J Neurol; 1980; 14(1):87-99. PubMed ID: 6983511
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis, diagnosis, and treatment of myasthenia (review of the foreign literature)].
    Vasil'ev VN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(11):1729-34. PubMed ID: 7006280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.